TCM

TCG Crossover Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 1,165.83%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+1,165.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.5B
AUM Growth
+$474M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
54
New
Increased
Reduced
Closed

Top Buys

1
+$94.1M
2
+$93.1M
3
+$85.6M
4
VOR icon
Vor Biopharma
VOR
+$80M
5
IMVT icon
Immunovant
IMVT
+$72.4M

Top Sells

1
+$87.5M
2
+$74.6M
3
+$65.3M
4
GPCR icon
Structure Therapeutics
GPCR
+$53.4M
5
LQDA icon
Liquidia Corp
LQDA
+$48.5M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABVX
1
Abivax
ABVX
$10.6B
$722M 20.65%
6,481,085
-630,511
CGON icon
2
CG Oncology
CGON
$5.49B
$248M 7.11%
3,670,206
TNGX icon
3
Tango Therapeutics
TNGX
$3.18B
$220M 6.3%
10,531,071
-2,231,023
COGT icon
4
Cogent Biosciences
COGT
$5.97B
$190M 5.45%
4,946,894
-921,268
CNTA
5
Centessa Pharmaceuticals
CNTA
$6.15B
$170M 4.87%
4,286,480
DNTH icon
6
Dianthus Therapeutics
DNTH
$5.08B
$141M 4.03%
1,676,624
TYRA icon
7
Tyra Biosciences
TYRA
$1.99B
$124M 3.56%
3,248,980
+350,877
IMVT icon
8
Immunovant
IMVT
$6.84B
$111M 3.17%
4,457,988
+2,797,055
BCRX icon
9
BioCryst Pharmaceuticals
BCRX
$2.26B
$105M 3%
+11,020,968
MIRM icon
10
Mirum Pharmaceuticals
MIRM
$6.19B
$98.1M 2.81%
1,062,049
+1,000,000
VOR icon
11
Vor Biopharma
VOR
$811M
$96.5M 2.76%
+5,673,078
SYRE icon
12
Spyre Therapeutics
SYRE
$6.38B
$95.9M 2.74%
1,900,582
AMLX icon
13
Amylyx Pharmaceuticals
AMLX
$1.6B
$86.8M 2.48%
6,243,812
IRON icon
14
Disc Medicine
IRON
$2.66B
$85.8M 2.45%
+1,341,862
DYN icon
15
Dyne Therapeutics
DYN
$3.2B
$83.7M 2.39%
4,615,144
GLUE icon
16
Monte Rosa Therapeutics
GLUE
$1.67B
$76M 2.18%
4,622,151
SVRA icon
17
Savara
SVRA
$1.07B
$67.5M 1.93%
12,362,205
RVMD icon
18
Revolution Medicines
RVMD
$33.5B
$56.1M 1.6%
576,473
+140,000
KOD icon
19
Kodiak Sciences
KOD
$2.3B
$55.1M 1.58%
1,445,538
LBRX
20
LB Pharmaceuticals
LBRX
$802M
$45.3M 1.3%
1,839,489
+94,474
SRZN icon
21
Surrozen
SRZN
$304M
$42.9M 1.23%
+1,473,101
ADCT icon
22
ADC Therapeutics
ADCT
$432M
$42.7M 1.22%
11,390,175
RLAY icon
23
Relay Therapeutics
RLAY
$3.06B
$42.5M 1.22%
4,273,356
+1,053,170
FULC icon
24
Fulcrum Therapeutics
FULC
$461M
$40.3M 1.15%
5,250,000
BHVN icon
25
Biohaven
BHVN
$1.66B
$39.2M 1.12%
4,631,317
1
2 3